With over 30 years of innovation, Sectra manages 170 million annual imaging exams and is a leading provider to health systems worldwide. Imaging modules for radiology, cardiology, pathology, orthopaedics, ophthalmology, and genomics, as well as a robust VNA and an optimized workflow engine, form an integrated enterprise diagnostic solution designed to support both human driven and AI driven clinical workflows. In 2026, Sectra won 7 Best in KLAS awards for the highest customer satisfaction. | With over 30 years of innovation and more than 2,500 sites managing 152 million annual imaging exams, Sectra is a leading provider to health systems worldwide. Sectra offers a complete enterprise solution comprised of imaging modules for radiology, cardiology, pathology, orthopaedics, ophthalmology, genomics, and a robust VNA. In 2025, Sectra won 8 Best in KLAS awards for customer satisfaction. We are excited to show you a wide range of new features, tools, and enhancements across our complete product portfolio.
SCT Ceramics
SCT Ceramics designs and manufactures custom implantable feedthroughs, casings, and windows for medical devices such as pacemakers, cochlear implants, and neurostimulators.We specialise in miniaturised, high-reliability ceramic components made from:•Alumina•Zirconia•Ruby•SapphireAll products undergo 100% inspection and testing, including:•Hermetic leak testing•Electrical tests•Thermal shock resistance•Dimensional checks (AQL standards)SCT Ceramics works closely with customers to create designs that match their device needs. Our teams focus on optimising cost, performance, and long-term reliability. We support every stage of development:•CAD design•Prototyping•Mass productionOur Medical Division is ISO 13485 certified, and our clean room meets ISO 8 standards. We collaborate with accredited labs and research partners to develop new materials and manufacturing methods.All solutions comply with FDA, CE, and NMPA regulations and follow ISO 10993 biocompatibility requirements. IQ, OQ, and PQ validation and continuous improvement tools—Six Sigma, 5S, SPC—are built into our processes. | We design and produce high voltage insulators tailored to the rigorous requirements of the medical imaging sector. Our clientele features leading global brands that adhere to the highest quality standards. PRODUCT PORTFOLIO Our clients demand electrical performance at 160 kV or more. For decades, our line of ALUCER® brazed products have demonstrated success in high voltage applications and we have the capacity to support small to large scale production. Our current offerings include: – Insulators – Feedthroughs – Anodes – Cathodes – Filament supports – R type receptable APPLICATIONS – CT scanners – X-ray scanners & tubes – Other powerful imaging devices hat require exceptional electrical performance
Sciomics
Protein profiling plays an essential part in today’s biomedical research, striving to improve patients’ quality of life by using molecular signatures for diagnosis and treatment guidance. At Sciomics, we believe that our explorative proteomic and post-translational modification profiling platform enables true progress in precision medicine. Therefore, our internal development pipeline of innovative biomarker signatures for precision medicine is based on this powerful platform. | Protein profiling plays a crucial role in the advancement of biomedical research, enabling us to improve patients’ quality of life by utilizing molecular signatures for accurate diagnosis and treatment. At Sciomics, our passion for advanced protein profiling is driving the future of Precision Medicine. We are continually expanding our biomarker signature pipeline to address a wide range of clinical indications and to advance Precision Diagnostics. Our cutting-edge services enable scientists worldwide to unravel the complexities of disease, uncover modes of action and identify promising protein biomarker candidates. Our service portfolio is anchored in our state-of-the-art scioDiscover microarray platform for protein and post-translational modification profiling. We are proud to support a wide range of research, from basic scientific discovery to breakthrough pharmaceutical initiatives (R&D). scioDiscover is a high-content, high-throughput system that provides a fast and cost-effective solution to your research needs. Its results are seamlessly translated into validation and clinical assays, enabling breakthrough biomarker discovery and preclinical drug development. | Sciomics has a robust immuno-proteomics platform for the development of protein biomarker panels as well as for the support of pre-clinical programs. On this basis we have established our own internal protein biomarker development pipeline and are offering CRO services for our customers in pharma and biotech. Currently, we are building a new venture bridging the gap between biomarker discovery, verification, and the introduction of our biomarker panels into the IVD market. The most advanced project focuses on scioAKI – a four-protein biomarker panel for an early and precise diagnosis of Acute Kidney Injury (AKI, for more details see asset scioAKI). Please get in touch if you are interested in partnering with us or investing in this endeavor. Our internal biomarker development pipeline, with the scioAKI project being our main program, is based on the scioDiscover platform. scioDiscover enables a robust combination of our proteomics data with AI-approaches for the definition of high-performance biomarker panels, both regarding sensitivity and specificity. As the platform is completely immuno-based, findings can be easily transferred to ELISA or similar tools for clinical routine use. In addition to our internal biomarker development pipeline, we offer CRO services based on our scioDiscover protein profiling platform and are welcoming R&D collaborations as well. Main applications are – the discovery and validation of novel biomarkers, – drug target screening, – the characterization of disease models, – the analysis of pathway activity as well as – mode-of-action studies. One of the key advantages in collaborating with us is our team of scientific experts that takes pride in custom-tailoring every project and consulting as well as supporting clients throughout the project. Our full-service ranges from discussing experimental designs to in-depth data analysis and yields a comprehensive study report. Fast and cost-efficient, Sciomics’ powerful high-content, high-throughput antibody array platform delivers reliable results that can be easily translated into validation or clinical assays. Thereby, we are a strong partner in generating value and opening new avenues for biomarker discovery, as well as target discovery and verification as well as preclinical drug development programs.
Scientist.com
Scientist.com is the world’s largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies. Scientist.com operates private marketplaces for most of the world’s major pharmaceutical companies and the US NIH. Visit scientist.com to learn more.
ScImage Inc
ScImage is a pioneer in cloud-native enterprise imaging, PACS, and image exchange solutions, trusted by leading healthcare organizations for over 30 years. The flagship PICOM365® platform delivers flexible, scalable, and secure enterprise medical imaging solutions designed to connect care teams, streamline workflows, and enhance patient outcomes — all while emphasizing strong, collaborative partnerships. PICOM365® powers multi-modality reading and reporting across all of radiology, with advanced hanging protocols, seamless AI integration, and zero-footprint access from anywhere. Scalable from independent imaging centers to multi-hospital health systems, PICOM365® also unifies cardiology, vascular, and other specialties — giving providers a single solution for every imaging workflow.
Science Care, Inc.
Science Care partners with qualified medical professionals in more than 75 countries to provide human anatomical specimens for surgical training, education, & research. New to Science Care is our ability to procure biospecimens through our Biobanking Division. Science Care also now offers anatomical models for both display & surgical training through our acquisition of Encoris. Visit our booth to discover our expanded offerings, all supporting orthopedic innovation & device development.
SCHOTT MINIFAB
SCHOTT MINIFAB provides integrated services for contract design, development and manufacturing of diagnostic and life science consumables – innovation to help you introduce new discoveries, enable precise health care treatments and improve patients outcomes. | SCHOTT MINIFAB provides contract design, development, and manufacturing services for companies in the diagnostics and life science industries. Our team of experts has a deep understanding of the industry-specific challenges and offers innovative solutions that drive cost-efficiencies and facilitate innovation. We specialize in streamlining the process from product development to pilot line to high-volume manufacturing of diagnostic or life science research consumables, with a focus on glass and polymer microfluidics and microarrays. | SCHOTT MINIFAB is your proven partner in contract design, development, and manufacturing for life science research and diagnostic consumables. We understand the hurdles in bringing novel innovations to full commercialization, so we have developed a process and infrastructure to meet your performance, quality, and cost requirements. Seamlessly transitioning from development to manufacturing, your product journey to improve patient care or to advance scientific discovery is closer to reality.
SCHOTT Pharma
Human health matters. That is why SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world. The portfolio comprises drug containment solutions and delivery systems for injectable drugs ranging from prefillable glass and polymer syringes to cartridges, vials, and ampoules. Every day, a team of around 4,700 people from over 60 nations works at SCHOTT Pharma to contribute to global healthcare. The company is represented in all main pharmaceutical hubs with 16 manufacturing sites in Europe, North and South America, and Asia. With over 1,000 patents and technologies developed in-house and a state-of-the-art R&D center in Switzerland, the company is focused on developing innovations for the future. SCHOTT Pharma AG & Co. KGaA is headquartered in Mainz, Germany and listed on the Frankfurt Stock Exchange as part of the MDAX. It is part of SCHOTT AG, which is owned by the Carl Zeiss Foundation. In light of this spirit, SCHOTT Pharma is committed to sustainable development for society and the environment and has the strategic goal of becoming climate-neutral by 2030. Currently, SCHOTT Pharma has over 1,800 customers including the top 30 leading pharma manufacturers for injectable drugs and generated revenue of EUR 957 million in the fiscal year 2024. Further information at www.schott-pharma.com Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social